ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Feb 11, 2019 Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information

Feb 07, 2019 Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2019 Financial Results on February 12, 2019

Jan 03, 2019 Elite Pharmaceuticals and SunGen Pharma File ANDA for an Antibiotic

Dec 10, 2018 Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall®

Nov 09, 2018 Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information

Nov 07, 2018 Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2019 Financial Results on November 12, 2018

Nov 05, 2018 Elite Pharmaceuticals Launches Generic Methadone Tablets

Oct 23, 2018 Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

Aug 14, 2018 Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

Aug 09, 2018 Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2019 Ended June 30, 2018 and Provides Conference Call Information

1 2 3 4 5 6 7 8 9 10 11

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.

Resize Viewer - Reduce

Resize Viewer - Expand